These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26230283)

  • 1. HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status.
    Richardson LA; El-Zein M; Ramanakumar AV; Ratnam S; Sangwa-Lugoma G; Longatto-Filho A; Cardoso MA; Coutlée F; Franco EL;
    Cancer Cytopathol; 2015 Dec; 123(12):745-54. PubMed ID: 26230283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
    Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
    Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge of the HPV status biases cytotechnologists' interpretation of Pap tests originally diagnosed as negative for intraepithelial lesion or malignancy.
    Doxtader EE; Brainard JA; Underwood D; Chute DJ
    Cancer Cytopathol; 2017 Jan; 125(1):60-69. PubMed ID: 27731938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of cytological test for cervices to identify human papillomavirus in the screening program on serious cervical lesion].
    Wang GP; Li RZ; Wu LN; Li J; Liu ZH; Wang C; Zhou YQ; Weng LM; Wu RF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):626-30. PubMed ID: 19957634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing national cervical cancer screening guidelines: Results from an HIV testing clinic also screening for cervical cancer and HPV in Soweto, South Africa.
    Hopkins KL; Jaffer M; Hlongwane KE; Otwombe K; Dietrich J; Cheyip M; Olivier J; Doherty T; Gray GE
    PLoS One; 2021; 16(7):e0255124. PubMed ID: 34329334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of single-, double- and triple-combined testing, including Pap test, HPV DNA test and cervicography, as screening methods for the detection of uterine cervical cancer.
    Kim JH; Kim IW; Kim YW; Park DC; Kim YW; Lee KH; Ahn TG; Han SJ; Ahn WS
    Oncol Rep; 2013 Apr; 29(4):1645-51. PubMed ID: 23443346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring mouse papillomavirus-associated cancer development using longitudinal Pap smear screening.
    Atkins HM; Uslu AA; Li JJ; Shearer DA; Brendle SA; Han C; Kozak M; Lopez P; Nayar D; Balogh KK; Abendroth C; Copper J; Cheng KC; Christensen ND; Zhu Y; Avril S; Burgener AD; Murooka TT; Hu J
    mBio; 2024 Aug; 15(8):e0142024. PubMed ID: 39012151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
    Jin XW; Xu H
    Compr Ther; 2001; 27(3):202-8. PubMed ID: 11569320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of human papillomavirus vaccination on cervical cancer screening in Alberta.
    Kim J; Bell C; Sun M; Kliewer G; Xu L; McInerney M; Svenson LW; Yang H
    CMAJ; 2016 Sep; 188(12):E281-E288. PubMed ID: 27378467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial vaginosis, aerobic vaginitis, vaginal inflammation and major Pap smear abnormalities.
    Vieira-Baptista P; Lima-Silva J; Pinto C; Saldanha C; Beires J; Martinez-de-Oliveira J; Donders G
    Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):657-64. PubMed ID: 26810061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based cohort study assessing the efficacy of cervical cytology (Pap smear) and human papillomavirus (HPV) testing as modalities for cervical cancer screening.
    Morisada T; Saika K; Saito E; Kono K; Saito H; Aoki D
    Jpn J Clin Oncol; 2018 May; 48(5):495-498. PubMed ID: 30535331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving cervical cancer screening in Mexico: results from the Morelos HPV Study.
    Flores Y; Bishai D; Lazcano E; Shah K; Lörincz A; Hernández M; Salmerón J
    Salud Publica Mex; 2003; 45 Suppl 3():S388-98. PubMed ID: 14746032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution.
    Kang M; Ha SY; Cho HY; Chung DH; Kim NR; An J; Lee S; Seok JY; Jeong J
    J Pathol Transl Med; 2020 Jan; 54(1):112-118. PubMed ID: 31964113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a real-time reference and calibration grid platform for improved screening - mapping in Pap test slides.
    Tsiambas E; Riziotis C
    Pathol Int; 2017 Jan; 67(1):24-31. PubMed ID: 27891686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening of cervical cancer--update].
    Dvorák V; Ondrus J
    Ceska Gynekol; 2010 Feb; 75(1):65-8. PubMed ID: 20437841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic tests for the detection of human papillomavirus-associated cervical lesions.
    Reuschenbach M; von Knebel Doeberitz M
    Curr Pharm Des; 2013; 19(8):1358-70. PubMed ID: 23016768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pap Cytology and Human Papillomavirus (HPV) Genotypes in Western Romania: A Retrospective Analysis.
    Ciurescu S; Ioan S; Gorun FI; Madalina CP; Ilas D; Larisa T
    Cureus; 2024 Jul; 16(7):e65720. PubMed ID: 39211696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.